Investor Relations

 

Shares Outstanding as of 6/30/09: 2,970,652 common shares
Insider Stock Ownership and Vested Options as of 4/13/09: 28.7%
52-week Trading Range: $1.33 – $4.75
Five-year Trading Range: $1.33 – $9.65
Incorporated: 1982 IPO Date: 1987
Fiscal Year End: December 31 Bank Debt: None
# of Employees: 30 Website: www.immucell.com

 

 

ImmuCell's purpose is to create scientifically-proven and practical products that result in a measurable economic impact on animal health and productivity in the dairy and beef industries.

Contact
Investor Relations:
Michael F. Brigham
President & CEO
ImmuCell Corporation
56 Evergreen Drive
Portland, Maine 04103
207-878-2770
mbrigham@immucell.com

For up-to-date quotes:

FlashQuote
Yahoo Finance
InfoQuote